FDA communication for medical devices is the structured process through which manufacturers interact with the U.S. FDA. The aim is to ensure compliance, safety, and timely approval of the products. It includes pre-submission meetings to clarify requirements, formal...
Selling medical devices in Europe is strategically valuable because the EU market is one of the largest and most regulated healthcare markets in the world. Achieving CE marking under the EU MDR or IVDR not only allows entry into Europe but also signals global...
Health Canada requires medical device manufacturers to conduct ongoing post-market surveillance. Mandatory summary reports, issue-related analyses, incident reporting, and foreign risk notifications are necessary requirements. Notably, these obligations apply...
MDEL annual license review (ALR) is a yearly renewal process for companies manufacturing, importing, or distributing medical devices in Canada. Health Canada oversees the ALR process. This review process ensures that MDEL holders remain consistently compliant with the...
CE marking is mandatory for marketing your cardiovascular medical devices in the EU market. It demonstrates compliance with EU MDR guidelines. The process of CE marking for cardiovascular medical devices is a rigorous, multi-step pathway. It ensures safety,...
India has eased medical device rules by removing the requirement for a separate loan licence when manufacturers outsource sterilisation. However, the sterilisation facility should hold a valid licence, with a six‑month transition period to update labels. Additionally,...